Elevate

Lycopodium Clavatum, Natrum Muriaticum, Sepia, Causticum, Phosphorus, Sulphur, 5-hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine, Phenylethylamine (hydrochloride), Serotonin (hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (suis), Diencephalon (suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (suis), Sarcolacticum Acidum, Faecalis (alkaligenes), Gaertner Bacillus (bach), Proteus (vulgaris)


Deseret Biologicals, Inc.
Human Otc Drug
NDC 43742-1036
Elevate also known as Lycopodium Clavatum, Natrum Muriaticum, Sepia, Causticum, Phosphorus, Sulphur, 5-hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine, Phenylethylamine (hydrochloride), Serotonin (hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (suis), Diencephalon (suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (suis), Sarcolacticum Acidum, Faecalis (alkaligenes), Gaertner Bacillus (bach), Proteus (vulgaris) is a human otc drug labeled by 'Deseret Biologicals, Inc.'. National Drug Code (NDC) number for Elevate is 43742-1036. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Elevate drug includes Acetylcholine Chloride - 8 [hp_X]/mL Adenosine Cyclic Phosphate - 10 [hp_X]/mL Alcaligenes Faecalis - 30 [hp_C]/mL Aluminum Oxide - 8 [hp_X]/mL Causticum - 4 [hp_X]/mL Dopamine Hydrochloride - 8 [hp_X]/mL Lactic Acid, L- - 10 [hp_X]/mL Lycopodium Clavatum Spore - 3 [hp_X]/mL Norepinephrine - 8 [hp_X]/mL Oxitriptan - 6 [hp_X]/mL and more. The currest status of Elevate drug is Active.

Drug Information:

Drug NDC: 43742-1036
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Elevate
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Lycopodium Clavatum, Natrum Muriaticum, Sepia, Causticum, Phosphorus, Sulphur, 5-hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine, Phenylethylamine (hydrochloride), Serotonin (hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (suis), Diencephalon (suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (suis), Sarcolacticum Acidum, Faecalis (alkaligenes), Gaertner Bacillus (bach), Proteus (vulgaris)
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Deseret Biologicals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACETYLCHOLINE CHLORIDE - 8 [hp_X]/mL
ADENOSINE CYCLIC PHOSPHATE - 10 [hp_X]/mL
ALCALIGENES FAECALIS - 30 [hp_C]/mL
ALUMINUM OXIDE - 8 [hp_X]/mL
CAUSTICUM - 4 [hp_X]/mL
DOPAMINE HYDROCHLORIDE - 8 [hp_X]/mL
LACTIC ACID, L- - 10 [hp_X]/mL
LYCOPODIUM CLAVATUM SPORE - 3 [hp_X]/mL
NOREPINEPHRINE - 8 [hp_X]/mL
OXITRIPTAN - 6 [hp_X]/mL
PANTOTHENIC ACID - 10 [hp_X]/mL
PHENETHYLAMINE HYDROCHLORIDE - 8 [hp_X]/mL
PHOSPHORUS - 4 [hp_X]/mL
PROTEUS VULGARIS - 30 [hp_C]/mL
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS - 30 [hp_C]/mL
SEPIA OFFICINALIS JUICE - 3 [hp_X]/mL
SEROTONIN HYDROCHLORIDE - 8 [hp_X]/mL
SILICON DIOXIDE - 8 [hp_X]/mL
SODIUM CHLORIDE - 3 [hp_X]/mL
SULFUR - 4 [hp_X]/mL
SUS SCROFA CEREBRUM - 10 [hp_X]/mL
SUS SCROFA DIENCEPHALON - 10 [hp_X]/mL
SUS SCROFA PINEAL GLAND - 10 [hp_X]/mL
SUS SCROFA UMBILICAL CORD - 10 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 20 Jul, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 Feb, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 05 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Deseret Biologicals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000175570
M0003647
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:AF73293C2R
E0399OZS9N
05KB30NGW2
LMI26O6933
DD5FO1WKFU
7L3E358N9L
F9S9FFU82N
C88X29Y479
X4W3ENH1CV
C1LJO185Q9
19F5HK2737
VOF61XW69D
27YLU75U4W
11T9HCO30O
Y3V16D4PV4
QDL83WN8C2
GKN429M9VS
ETJ7Z6XBU4
451W47IQ8X
70FD1KFU70
4GB5DQR532
23PJ4252VL
050QZ2EDK7
118OYG6W3H
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Catecholamine [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class CS:Catecholamines [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Catecholamine [EPC]
Catecholamines [CS]
Cholinergic Agonists [MoA]
Cholinergic Receptor Agonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
43742-1036-130 mL in 1 BOTTLE, DROPPER (43742-1036-1)20 Jul, 201704 Feb, 2024No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Homeopathic indications: for temporary relief of symptoms including difficulty sleeping or concentrating, loss of appetite, irritability, feelings of hopelessness and self-loathing.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Product Elements:

Elevate lycopodium clavatum, natrum muriaticum, sepia, causticum, phosphorus, sulphur, 5-hydroxytryptophan, alumina, silicea, acetylcholine chloride, dopamine hydrochloride, norepinephrine, phenylethylamine (hydrochloride), serotonin (hydrochloride), adenosinum cyclophosphoricum, cerebrum (suis), diencephalon (suis), funiculus umbilicalis suis, pantothenic acid, pineal gland (suis), sarcolacticum acidum, faecalis (alkaligenes), gaertner bacillus (bach), proteus (vulgaris) lycopodium clavatum spore lycopodium clavatum spore sodium chloride chloride ion sepia officinalis juice sepia officinalis juice causticum causticum phosphorus phosphorus sulfur sulfur oxitriptan oxitriptan aluminum oxide aluminum oxide silicon dioxide silicon dioxide acetylcholine chloride acetylcholine dopamine hydrochloride dopamine norepinephrine norepinephrine phenethylamine hydrochloride phenethylamine serotonin hydrochloride serotonin adenosine cyclic phosphate adenosine cyclic phosphate sus scrofa cerebrum sus scrofa cerebrum sus scrofa diencephalon sus scrofa diencephalon sus scrofa umbilical cord sus scrofa umbilical cord pantothenic acid pantothenic acid sus scrofa pineal gland sus scrofa pineal gland lactic acid, l- lactic acid, l- alcaligenes faecalis alcaligenes faecalis salmonella enterica subsp. enterica serovar enteritidis salmonella enterica enterica serovar enteritidis proteus vulgaris proteus vulgaris water alcohol

Indications and Usage:

Homeopathic indications: for temporary relief of symptoms including difficulty sleeping or concentrating, loss of appetite, irritability, feelings of hopelessness and self-loathing.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Warnings:

Warnings: keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. if pregnant or breast-feeding, ask a health professional before use. tamper seal: sealed for your protection. do not use if seal is broken or missing.

Dosage and Administration:

Directions: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: des bio ndc 43742-1036-1 homeopathic elevate 1 fl oz (30 ml) elevate

Further Questions:

Questions: dist. by: deseret biologicals, inc. 469 w. parkland drive sandy, ut 84070 www.desbio.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.